Open access
Open access
Powered by Google Translator Translator

Diabetes

RCT | Efficacy of a digital behavioral therapeutic application to improve glycemic control in adults with Type 2 DM.

7 Nov, 2022 | 12:33h | UTC

Randomized, Controlled Trial of a Digital Behavioral Therapeutic Application to Improve Glycemic Control in Adults With Type 2 Diabetes – Diabetes Care

Commentary: Smartphone-delivered CBT improves glycemic control in people with type 2 diabetes – medwire News

 


Crossover RCT | Efficacy of low-dose Empagliflozin as an adjunct to hybrid closed-loop insulin therapy in adults with Type 1 DM.

7 Nov, 2022 | 12:24h | UTC

Low-Dose Empagliflozin as Adjunct to Hybrid Closed-Loop Insulin Therapy in Adults With Suboptimally Controlled Type 1 Diabetes: A Randomized Crossover Controlled Trial – Diabetes Care (link to abstract – $ for full-text)

 


Study suggests a personalized frequency of urinary albumin screening may be best for patients with Type 1 Diabetes.

3 Nov, 2022 | 13:46h | UTC

Optimal Frequency of Urinary Albumin Screening in Type 1 Diabetes – Diabetes Care (link to abstract – $ for full-text)

News Release: NIH-funded study finds personalized kidney screening for people with type 1 diabetes could reduce costs, detect disease earlier – National Institutes of Health

 


Development, validation and clinical utility of a risk prediction model for adverse pregnancy outcomes in gestational diabetes.

3 Nov, 2022 | 13:45h | UTC

Development, validation and clinical utility of a risk prediction model for adverse pregnancy outcomes in women with gestational diabetes: The PeRSonal GDM model – eClinicalMedicine

 

Commentary on Twitter (thread – click for more)

 


M-A | Association of SGLT2 inhibitors with cardiovascular outcomes and safety events.

1 Nov, 2022 | 11:56h | UTC

Association of sodium-glucose cotransporter 2 inhibitors with cardiovascular outcome and safety events: A meta-analysis of randomized controlled clinical trials – Frontiers in Cardiovascular Medicine

 


M-A of RCT | Comparison of low carbohydrate vs. low fat diets in Type 2 DM.

31 Oct, 2022 | 13:55h | UTC

Comparison of the Effectiveness of Low Carbohydrate Versus Low Fat Diets, in Type 2 Diabetes: Systematic Review and Meta-Analysis of Randomized Controlled Trials – Nutrients

 


RCT | Effects of a low-carbohydrate dietary intervention on hemoglobin A1c.

31 Oct, 2022 | 13:54h | UTC

Effects of a Low-Carbohydrate Dietary Intervention on Hemoglobin A1c: A Randomized Clinical Trial – JAMA Network Open

See also: Visual Abstract

News Release: At risk for diabetes? Cut the carbs, says new study – Tulane University

Commentaries:

Expert reaction to study looking at effects of a low-carbohydrate dietary intervention and improved glycaemia – Science Media Centre

Low-Carb Diet Promising for Lowering Blood Sugar in Prediabetes – TCTMD

 


Cohort Study | Risk factors of pancreatic cancer in patients with Type 2 DM.

31 Oct, 2022 | 13:47h | UTC

Risk Factors of Pancreatic Cancer in Patients With Type 2 Diabetes Mellitus: The Hong Kong Diabetes Study – Journal of the Endocrine Society

 


M-A | Age, sex, race, BMI, and duration of type 2 DM differences in cardiovascular outcomes with glucose lowering drugs.

26 Oct, 2022 | 14:32h | UTC

Age, sex, race, BMI, and duration of diabetes differences in cardiovascular outcomes with glucose lowering drugs in type 2 diabetes: A systematic review and meta-analysis – eClinicalMedicine

Commentary: Meta-analysis may guide optimal type 2 diabetes glucose-lowering agent for MACE protection – medwire News

 


KDIGO 2022 Clinical practice guideline for diabetes management in chronic kidney disease.

24 Oct, 2022 | 14:16h | UTC

KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease – Kidney International

See also: Executive summary of the KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease: an update based on rapidly emerging new evidence – Kidney International

Related: ADA/KDIGO Consensus Report | Diabetes management in chronic kidney disease.

 


M-A | Safety of sotagliflozin in diabetes mellitus type 1 and type 2.

19 Oct, 2022 | 14:12h | UTC

The safety of sotagliflozin in the therapy of diabetes mellitus type 1 and type 2: A meta-analysis of randomized trials – Frontiers in Endocrinology

 


M-A | Cardiovascular and renal efficacy and safety of sodium-glucose cotransporter-2 inhibitors in patients without diabetes.

19 Oct, 2022 | 14:11h | UTC

Cardiovascular and renal efficacy and safety of sodium-glucose cotransporter-2 inhibitors in patients without diabetes: a systematic review and meta-analysis of randomised placebo-controlled trials – BMJ Open

 


Retrospective Cohort Study | Trends in the association between diabetes and cardiovascular events, 1994-2019.

18 Oct, 2022 | 12:58h | UTC

Trends in the Association Between Diabetes and Cardiovascular Events, 1994-2019 – JAMA (free for a limited period)

Related Study: Study shows that the leading causes of hospitalization of adults with diabetes are changing.

 


RCT | Two-year effects of Semaglutide in adults with overweight or obesity.

18 Oct, 2022 | 12:53h | UTC

Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial – Nature Medicine

Commentary: STEP 5: Sustained semaglutide treatment maintains weight loss – medwire News

Related:

RCT: Effect of continued weekly subcutaneous Semaglutide vs. placebo on weight loss maintenance in adults with overweight or obesity

RCT: High dose once a week Semaglutide (2.4 mg) in adults with overweight or obesity, and type 2 diabetes

RCT: Effect of high-dose subcutaneous Semaglutide vs. placebo in adults with overweight or obesity

RCT: Once-weekly, high-dose semaglutide is effective for improving overweight or obesity among non-diabetic adults

 

Commentary on Twitter

 


Cohort Study | Duration of diabetes and use of insulin are the most important predictors of diabetic retinopathy.

13 Oct, 2022 | 13:44h | UTC

Presence and development of diabetic retinopathy in 153 238 patients with type 2 diabetes in the Danish Registry of Diabetic Retinopathy – Acta Ophthalmologica

Commentary: Insulin Use May Predict the Development of Diabetic Retinopathy – HCP Live

 


Cohort Study | Effect of diabetes on morbidity and mortality in patients with acromegaly.

13 Oct, 2022 | 13:37h | UTC

Effect of Diabetes on Morbidity and Mortality in Patients With Acromegaly – The Journal of Clinical Endocrinology & Metabolism

 

Commentary on Twitter

 


Calculator | Estimating individual lifetime risk of cardiovascular events in adults with type 2 diabetes.

11 Oct, 2022 | 13:29h | UTC

Estimating individual lifetime risk of incident cardiovascular events in adults with type 2 diabetes: an update and geographical calibration of the DIAbetes Lifetime perspective model (DIAL2) – European Journal of Preventive Cardiology

See also: DIAL Model Calculator

 


Diabetic kidney disease back in focus: management field guide for health care professionals in the 21st century.

7 Oct, 2022 | 14:08h | UTC

Diabetic Kidney Disease Back in Focus: Management Field Guide for Health Care Professionals in the 21st Century – Mayo Clinic Proceedings

Related: ADA/KDIGO Consensus Report | Diabetes management in chronic kidney disease.

 


EASD/ADA Consensus Report | Automated insulin delivery: benefits, challenges, and recommendations.

6 Oct, 2022 | 13:46h | UTC

Automated insulin delivery: benefits, challenges, and recommendations. A Consensus Report of the Joint Diabetes Technology Working Group of the European Association for the Study of Diabetes and the American Diabetes Association – Diabetologia (if the link is paywalled, try this one)

Related: Consensus Recommendations for the Use of Automated Insulin Delivery (AID) Technologies in Clinical Practice – Endocrine Reviews

 


ADA/KDIGO Consensus Report | Diabetes management in chronic kidney disease.

5 Oct, 2022 | 13:59h | UTC

Diabetes Management in Chronic Kidney Disease: A Consensus Report by the American Diabetes Association (ADA) and Kidney Disease: Improving Global Outcomes (KDIGO) – Kidney International

News Release: NEWS RELEASE: ADA & KDIGO Release Joint Consensus Report on Diabetes Management in CKD

 


Cohort Study | Diabetes diagnosed at younger ages is associated with increased morbidity compared to diagnosis in older adults.

3 Oct, 2022 | 14:02h | UTC

Associations of Age at Diagnosis and Duration of Diabetes With Morbidity and Mortality Among Older Adults – JAMA Network Open

 


RCT | In patients with Type 1 Diabetes, the use of a “bionic pancreas” reduced HbA1c without increasing hypoglycemia.

29 Sep, 2022 | 13:35h | UTC

Multicenter, Randomized Trial of a Bionic Pancreas in Type 1 Diabetes – New England Journal of Medicine (link to abstract – $ for full-text)

News Release: Bionic pancreas improves type 1 diabetes management compared to standard insulin delivery methods – National Institutes of Health

 


ADA/EASD Consensus Report | Management of Hyperglycemia in Type 2 Diabetes, 2022.

26 Sep, 2022 | 12:11h | UTC

Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) – Diabetes Care

News Release: ADA/EASD Consensus Update on Management of Hyperglycemia in Type 2 Diabetes – Report Published in Diabetes Care – American Diabetes Association

Commentary: ADA/EASD hyperglycemia management consensus update strengthens holistic care – medwire News

 


M-A | Association of gestational diabetes mellitus with cardiovascular and cerebrovascular diseases.

26 Sep, 2022 | 12:01h | UTC

Association of gestational diabetes mellitus with overall and type specific cardiovascular and cerebrovascular diseases: systematic review and meta-analysis – The BMJ

News Release: Diabetes in pregnancy linked to risk of cardiovascular and cerebrovascular disease – BMJ Newsroom

 

Commentary on Twitter

 


Cohort Study | Modifiable risk factors may reduce the risk of type 2 diabetes in patients with a history of gestational diabetes.

23 Sep, 2022 | 13:08h | UTC

Modifiable risk factors and long term risk of type 2 diabetes among individuals with a history of gestational diabetes mellitus: prospective cohort study – The BMJ

News Release: Healthy lifestyle linked to 90% lower risk of diabetes in susceptible women – BMJ Newsroom

 

Commentary on Twitter

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.